Shortening the Diagnostic Odyssey

RARECast - A podcast by RARECast - Thursdays

Categories:

Business

Katherine Stueland, CEO of GeneDx, discusses the state of genetic testing, what its 2022 acquisition by the AI-drive genomics company SEMA4 has meant to it, and what she thinks it will take to make meaningful change to the diagnostic odyssey.